https://www.selleckchem.com/
1], 7.35 × 109/L [5.3-10.5], 10.7 × 109/L [7.7-16.8], respectively, P less then 0.0001). The maximal IPF% among the Covid-19 group was higher than the stable group and similar to the AMI group. The maximal IPC in Covid-19 was higher than the maximal IPC in both the stable and AMI groups (COVID-19 14.4 × 109/L [9.4-20.9], AMI 10.9 × 109/L [7.6-15.2], P = 0.0035, Stable 7.55 × 109/L [5.55-10.5], P less then 0.0001). Patients with Covid-19 have increased immature platelets indices compared to stable patients with cardiovascular risk factors, and as the disease
Like
Comment
Share
